OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries
May 12 2020 - 7:00AM
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in
point-of-care diagnostic tests, specimen collection devices, and
microbiome laboratory and analytical services, today
announced that its Diversigen and CoreBiome subsidiaries have
combined their microbiome service offerings under the Diversigen
name. The rebrand highlights the combined companies’ unparalleled
scientific bench strength, state-of-the-art laboratory, ability to
translate data to insights and collective focus on quality and
service.
The unified Diversigen operation will continue
to offer the science-driven, customized solutions for metagenomics
sequencing, bioinformatics, and statistical analysis for the study
of the microbiome for which CoreBiome and Diversigen are known. The
unification elevates Diversigen as the cornerstone brand for
microbiome services in the industry.
The combined organization includes scientific
experts representing more than a century of microbiome experience
and over 300 articles in respected scientific publications with
more than 100,000 citations.
“The new Diversigen brand reflects the combined
strength and innovation of these two microbiome service pioneers
and positions the OraSure family of companies as an industry leader
in this fast-growing industry. Together they will enable us to
expand our services as we work to advance global health and bring
our customers the tools, services and data-driven insights they
need to get reliable, actionable answers to their most critical
scientific and healthcare questions,” said Stephen S. Tang, Ph.D.,
President and Chief Executive Officer, OraSure Technologies,
Inc.
All services previously offered under the
CoreBiome brand will continue to be available from Diversigen,
offering the microbiome market unparalleled choice in sequencing,
bioinformatics and analysis services.
The rebrand was implemented after in-depth
research, market analysis, and customer conversations. A new
Diversigen logo will bring a sharp new visual identity,
representing the best of both CoreBiome and Diversigen and
characterizes the brand as smart, market-driven, and
innovative.
The new Diversigen website is available at
diversigen.com.
About OraSure Technologies
OraSure Technologies empowers the global
community to improve health and wellness by providing access to
accurate, essential information. Together with its wholly owned
subsidiaries (DNA Genotek, Diversigen and Novosanis), OraSure
provides its customers with end-to-end solutions that encompass
tools, services and diagnostics. The OraSure family of companies is
a leader in the development, manufacture, and distribution of rapid
diagnostic tests, sample collection and stabilization devices, and
molecular services solutions designed to discover and detect
critical medical conditions. OraSure’s portfolio of products is
sold globally to clinical laboratories, hospitals, physician’s
offices, clinics, public health and community-based organizations,
research institutions, government agencies, pharma, commercial
entities and direct to consumers. For more information on OraSure
Technologies, please visit www.orasure.com.
About Diversigen
Diversigen is powering microbiome discovery
through sequencing, analysis, and consulting services geared toward
the study of the microbiome of living organisms and environments.
By working closely with key manufacturers and applying laboratory
best practices, Diversigen has developed state-of-the-art
techniques to extract high quality nucleic acids from a variety of
sample types for subsequent metagenomic analysis. Diversigen’s
flexible sequencing and computing capacity, combined with ongoing
improvement of analytic tools and their applications, allow them to
customize unique strategies on a per-project basis. Diversigen
takes pride in one-on-one consultation with the customer until
complete satisfaction is achieved. The services offered cover the
full spectrum from organism detection, to analysis, modification,
and consultation.
Investor Contact: Roberto
CucaChief Financial Officer610-882-1820
investorinfo@orasure.com |
Media Contact: Jeanne MellVP
Corporate Communications484-353-1575media@orasure.com |
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024